APA (7th ed.) Citation

Scheithauer, W., Riera-Knorrenschild, J., Kopp, H., Nitsche, D., Kuhlmann, J., Zurlo, A., & Schmoll, H. (2014). 3O LONG-TERM MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703 IN A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS FROM THE IMPACT STUDY. Annals of Oncology, 25(suppl_6), vi1. https://doi.org/10.1093/annonc/mdu466.3

Chicago Style (17th ed.) Citation

Scheithauer, W., J. Riera-Knorrenschild, H. Kopp, D. Nitsche, J. Kuhlmann, A. Zurlo, and H.J Schmoll. "3O LONG-TERM MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703 IN A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS FROM THE IMPACT STUDY." Annals of Oncology 25, no. suppl_6 (2014): vi1. https://doi.org/10.1093/annonc/mdu466.3.

MLA (9th ed.) Citation

Scheithauer, W., et al. "3O LONG-TERM MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703 IN A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS FROM THE IMPACT STUDY." Annals of Oncology, vol. 25, no. suppl_6, 2014, p. vi1, https://doi.org/10.1093/annonc/mdu466.3.